Trizivir

Active Ingredient(s): Abacavir + Lamivudine, 3TC + Zidovudine, ZDV
FDA Approved: * November 14, 2000
Pharm Company: * GLAXOSMITHKLINE
Category: HIV / AIDS

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Trizivir Overview

Abacavir/lamivudine/zidovudine, sold under the trade name Trizivir, is a medication for HIV infection.[1] It is a fixed dose combination of three reverse transcriptase inhibitors patented by GlaxoSmithKline and marketed by a joint venture with Pfizer, ViiV Healthcare:[2] abacavir (ABC) lamivudine (3TC) zidovudine (AZT or ZDV) It is indicated in the treatment of AIDS/HIV.[3] For this purpose, the combination is very useful in pregnant women to d...

Read more Trizivir Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Abacavir/lamivudine/zidovudine

Recent Trizivir Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Abacavir + Lamivudine, 3TC + Zidovudine, ZDV
  • Tablet: 300mg + 150mg + 300mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Trizivir: (2 results)

Sorted by National Drug Code
  • 49702-217 Trizivir (Abacavir 300 mg / Lamivudine 150 mg / Zidovudine 300 mg) Oral Tablet by Viiv Healthcare Company
  • 53808-0990 Trizivir Oral Tablet, Film Coated by State of Florida Doh Central Pharmacy

Drugs with one or more similar ingredients: (16 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA